Akkar, M. E., Ortaakarsu, A. B., Boğa, Ö. B., Kurbanoğlu, E. B., & Altundas, A. (2026). Novel 4-Bromobenzyl-1H-1,2,3-Triazole Scaffold for Multi-target Enzyme Inhibition in Helicobacter Gastric Injury via Experimental and Computational Approaches. Journal of Pharmaceutical Innovation: From R&D to Market, 21(1), . https://doi.org/10.1007/s12247-025-10298-9
Παραπομπή σε μορφή Chicago (17η εκδ.)Akkar, Mehmet Eren, Ahmet Buğra Ortaakarsu, Özlem Bakır Boğa, Esabi Başaran Kurbanoğlu, και Aliye Altundas. "Novel 4-Bromobenzyl-1H-1,2,3-Triazole Scaffold for Multi-target Enzyme Inhibition in Helicobacter Gastric Injury via Experimental and Computational Approaches." Journal of Pharmaceutical Innovation: From R&D to Market 21, no. 1 (2026). https://doi.org/10.1007/s12247-025-10298-9.
Παραπομπή σε μορφή MLA (9th εκδ.)Akkar, Mehmet Eren, et al. "Novel 4-Bromobenzyl-1H-1,2,3-Triazole Scaffold for Multi-target Enzyme Inhibition in Helicobacter Gastric Injury via Experimental and Computational Approaches." Journal of Pharmaceutical Innovation: From R&D to Market, vol. 21, no. 1, 2026, https://doi.org/10.1007/s12247-025-10298-9.